These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 3850903)

  • 21. Mapping of C2, Bf, and C4 genes to the swine major histocompatibility complex (swine leukocyte antigen).
    Lie WR; Rothschild MF; Warner CM
    J Immunol; 1987 Nov; 139(10):3388-95. PubMed ID: 2890688
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular regulation of MHC class III (C4 and factor B) gene expression in mouse peritoneal macrophages.
    Sackstein R; Colten HR
    J Immunol; 1984 Sep; 133(3):1618-26. PubMed ID: 6205089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Type II human complement C2 deficiency. Allele-specific amino acid substitutions (Ser189 --> Phe; Gly444 --> Arg) cause impaired C2 secretion.
    Wetsel RA; Kulics J; Lokki ML; Kiepiela P; Akama H; Johnson CA; Densen P; Colten HR
    J Biol Chem; 1996 Mar; 271(10):5824-31. PubMed ID: 8621452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of complement proteins C2 and factor B by interleukin-1 and interferon-gamma acting on transfected L cells.
    Perlmutter DH; Strunk RC; Goldberger G; Cole FS
    Mol Immunol; 1986 Nov; 23(11):1263-6. PubMed ID: 3029573
    [No Abstract]   [Full Text] [Related]  

  • 25. Molecular genetics of the major histocompatibility linked complement genes.
    Colten HR
    Springer Semin Immunopathol; 1983; 6(2-3):149-58. PubMed ID: 6356428
    [No Abstract]   [Full Text] [Related]  

  • 26. Structure organization and expression of the major histocompatibility class III genes.
    Colten HR
    Ann N Y Acad Sci; 1985; 458():269-76. PubMed ID: 3911849
    [No Abstract]   [Full Text] [Related]  

  • 27. Constitutive and IL 1-regulated murine complement gene expression is strain and tissue specific.
    Falus A; Beuscher HU; Auerbach HS; Colten HR
    J Immunol; 1987 Feb; 138(3):856-60. PubMed ID: 3492536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum-treated antigen-antibody complexes inhibit the production of C2 and factor B by mononuclear phagocytes.
    Whaley K; Lappin D; Hamilton AO
    Immunology; 1983 Feb; 48(2):255-63. PubMed ID: 6549747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA polymorphism of the C2 and factor B genes. Detection of a restriction fragment length polymorphism which subdivides haplotypes carrying the C2C and factor B F alleles.
    Cross SJ; Edwards JH; Bentley DR; Campbell RD
    Immunogenetics; 1985; 21(1):39-48. PubMed ID: 2981769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Are major histocompatibility system class III products independent markers for susceptibility to rheumatoid arthritis?
    Dyer PA; Thomson W; Sanders PA; Grennan DM
    Dis Markers; 1986 Jun; 4(1-2):151-5. PubMed ID: 3330696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of class III major histocompatibility complex gene products by interleukin-1.
    Perlmutter DH; Goldberger G; Dinarello CA; Mizel SB; Colten HR
    Science; 1986 May; 232(4752):850-2. PubMed ID: 3010455
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA polymorphism of MHC III genes in inbred and wild mouse strains.
    Falus A; Wakeland EK; McConnell TJ; Gitlin J; Whitehead AS; Colten HR
    Immunogenetics; 1987; 25(5):290-8. PubMed ID: 2883115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biosynthesis of a structurally abnormal C2 complement protein by macrophages from C2-deficient guinea pigs.
    Goldberger G; Cole FS; Einstein LP; Auerbach HS; Bitter-Suermann D; Colten HR
    J Immunol; 1982 Nov; 129(5):2061-5. PubMed ID: 6922142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcriptional termination between the closely linked human complement genes C2 and factor B: common termination factor for C2 and c-myc?
    Ashfield R; Enriquez-Harris P; Proudfoot NJ
    EMBO J; 1991 Dec; 10(13):4197-207. PubMed ID: 1756727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conservation of the RD-BF-C2 organization in the pig MHC class-III region: mapping and cloning of the pig RD gene.
    Peelman LJ; Mattheeuws M; Van Zeveren A; van de Weghe A; Bouquet Y
    Anim Genet; 1996 Feb; 27(1):35-42. PubMed ID: 8624034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tissue-specific pretranslational regulation of complement production in human mononuclear phagocytes.
    Cole FS; Auerbach HS; Goldberger G; Colten HR
    J Immunol; 1985 Apr; 134(4):2610-6. PubMed ID: 3844437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum concentrations of C4 isotypes and factor B in type I C2 deficiency suggest haplotype-dependent quantitative expression of MHC class III complement genes.
    Truedsson L; Gullstrand B; Jönsson T; Klint C
    Exp Clin Immunogenet; 1995; 12(2):66-73. PubMed ID: 7576717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNA polymorphism of the C2 locus.
    Bentley DR; Campbell RD; Cross SJ
    Immunogenetics; 1985; 22(4):377-90. PubMed ID: 2997031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of synthesis of complement protein C4 in human fibroblasts: cell- and gene-specific effects of cytokines and lipopolysaccharide.
    Kulics J; Circolo A; Strunk RC; Colten HR
    Immunology; 1994 Aug; 82(4):509-15. PubMed ID: 7835912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of complement gene expression.
    Colten HR; Dowton SB
    Biochem Soc Symp; 1986; 51():37-46. PubMed ID: 3101700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.